MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2019 International Congress

    Acute hemichorea caused by infarction over globus pallidus interna

    YP. Chang (Kaohsiung, Taiwan)

    Objective: To report a case of acute hemichorea after infarction over globus pallidus interna Background: Movement disorders occurred after stroke have been recognized in previous…
  • 2019 International Congress

    Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

    K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

    Objective: To clinically characterize a Huntington's disease patient with two reduced penetrance alleles. Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder manifesting with…
  • 2019 International Congress

    Subcortical atrophy is an early event in Huntington’s disease

    N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To determine whether brain regional volumes are associated with clinical symptoms in premanifest and manifest Huntington’s disease (HD). Background: Striatal atrophy has been considered a…
  • 2019 International Congress

    Movement disorders in neurologic consultation of Marrakesh University Hospital

    L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

    Objective: Describing the epidemiological and clinical aspects of the movement’s disorders in Marrakesh. Analyzing difficulties of management of this disease. Comparing our data with international…
  • 2019 International Congress

    Insomnia as clinical onset symptom in Juvenile Huntington’s Disease: Evaluation of a Family

    M. Gultekin (Kayseri, Turkey)

    Objective: The aim of this study to emphasize that three juvenile form of HD cases who have insomnia as clinical onset symptoms. Background: Huntington’s Disease…
  • 2019 International Congress

    NBIA-like MRI findings in a patient with Huntington’s disease

    T. Shimizu, T. Matsukawa, Y. Abe, H. Suga, N. Tominaga, M. Nagai, T. Iizuka, H. Ishiura, J. Mitsui, S. Tsuji, R. Hanajima, K. Nishiyama (Yonago, Japan)

    Objective: To report a rare case of Huntington’s disease (HD) with MRI findings resembling neurodegeneration with brain iron accumulation (NBIA). Background: HD and NBIA are…
  • 2019 International Congress

    The spectrum of involuntary vocalizations in humans

    T. Mainka, B. Balint, F. Gövert, L. Kurvits, C. van Riesen, A. Kühn, M. Tijssen, A. Lees, K. Müller-Vahl, K. Bhatia, C. Ganos (London, United Kingdom)

    Objective: To provide a detailed overview of the wide spectrum of involuntary vocalizations in humans, their etiologies and treatment recommendations. Background: Abnormal vocalizing behaviors are…
  • 2019 International Congress

    Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

    L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)

    Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…
  • 2019 International Congress

    Usefulness of Heart Rate Variability to Identify the Risk of Falling in Huntington’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the relationship between the HRV and the risk of falling in HD patients. Background: Huntington's disease (HD) patients have a high prevalence…
  • 2019 International Congress

    Non-motor Symptoms in Hyperkinetic Movement Disorders

    H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: To evaluate the frequencies and clinical features of non-motor symptoms in several different hyperkinetic movement disorders and compare them with the healthy age- and…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley